KENYA — Kenya’s efforts towards achieving universal healthcare have taken a significant leap forward with the announcement of a partnership with Univercells, a Belgian biotech company, to establish a biotechnology…
Read MoreCategory: Pharmaceuticals
Takeda ramps up production capacity for plasma-derived therapies with US$765M investment in Japanese facility
JAPAN —Takeda Pharmaceutical Company Limited has announced that it will invest approximately US$764.6 million to construct a new manufacturing facility for plasma-derived therapies (PDTs) in Osaka, Japan. This significant investment…
Read MoreMajor drug manufacturers partner with Amazon to integrate coupons for their products
USA — Amazon Pharmacy has formed partnerships with notable manufacturers such as GSK, Kaléo, Novo Nordisk, and Dexcom to offer their brand-name drugs, including Trelegy, AUVI-Q, Wegovy, and the G6…
Read MoreGhana’s Ministry of Health and FDA take measures to ensure usage of only registered products
GHANA — Ms. Deborah Djanie, Director of the Ministry of Health, has announced the Ministry’s collaboration with the Food and Drugs Authority (FDA) to improve market surveillance and enforce the…
Read MoreGhana FDA issues warning on contaminated eye drops in circulation
GHANA — The Food and Drugs Authority (FDA) has issued a warning to the general public regarding the use of two brands of contaminated eye drops that are currently on…
Read MoreVertex expands investment in CRISPR Therapeutics for diabetes treatment development
USA — Vertex Pharmaceuticals has inked a non-exclusive licensing deal with CRISPR Therapeutics to expedite the development of its hypo immune cell therapies for the treatment of type 1 diabetes…
Read MoreMerck KGaA and Pfizer end collaboration on cancer drug Bavencio
GERMANY— Merck KGaA has regained global rights to anti-PD-L1 antibody Bavencio (avelumab) as its agreement with Pfizer has ended. The news comes just a few weeks after Pfizer announced plans…
Read MoreUK regulator introduces major updates to streamline trials and attract global studies
UNITED KINGDOM — The Medicines and Healthcare products Regulatory Agency (MHRA) has introduced a new framework that aims to streamline the process for drugmakers to gain approval for new medicines…
Read MoreZynyz receives FDA accelerated approval for treatment of Merkel Cell Carcinoma
USA — Incyte’s Zynyz (retifanlimab-dlwr) has received accelerated approval from the FDA for the treatment of metastatic or recurrent locally advanced Merkel cell carcinoma (MCC) in adults. MCC is a…
Read MoreDanaher to tackle manufacturing hurdles affecting cell therapies
USA — Danaher has announced a new collaboration with the University of Pennsylvania (Penn) aimed at addressing the manufacturing challenges that limit the consistency of clinical outcomes and slow the…
Read More